Literature DB >> 31140428

[Plasma levels of interferon-inducible protein 10 in patients with active pulmonary tuberculosis with different affected areas].

Haiping Dong1, Zhihui Liu1, Xiaocheng Liang1, Yiluan Jian1, Dexian Li1, Suihua Lao1, Feng Liang1, Yanshan Pan1, Xiaojia Kuang1.   

Abstract

OBJECTIVE: To explore the value of interferon-inducible protein 10 (IP-10) in the auxiliary diagnosis of tuberculosis and the judgment of the severity of disease.
METHODS: From February, 2013 to February, 2017, a total of 193 patients with TB admitted in our hospital and 84 healthy control subjects were recruited consecutively. The peripheral blood plasma levels of interferon-γ (IFN-γ) and IP-10 were detected using liquid phase chip (Luminex) technique. According to the number of lung fields affected by TB, the patients were divided into group A (with lesions in 1-2 lung fields), group B (3-4 lung fields) and group C (5-6 lung fields), The expressions of IFN-γ and IP-10 in 3 groups were compared.
RESULTS: The plasma levels of IP-10 were significantly higher in TB patients than in the control subjects (P < 0.05), but IFN-γ levels were comparable between the two groups (P > 0.05). Among the TB patients, plasma IP-10 levels was the highest in group C (P < 0.05), and IFN-γ levels did not differ significantly among the 3 groups (P > 0.05).
CONCLUSIONS: Plasma IP-10 has a certain reference value in the auxiliary diagnosis of active tuberculosis and the judgment of the severity of the disease.

Entities:  

Keywords:  auxiliary diagnosis; interferon-inducible protein 10; pulmonary tuberculosis; severity of the disease

Mesh:

Substances:

Year:  2019        PMID: 31140428      PMCID: PMC6743946          DOI: 10.12122/j.issn.1673-4254.2019.05.18

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  22 in total

1.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

2.  Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.

Authors:  Yun Hee Jeong; Yun-Gyoung Hur; Hyejon Lee; Sunghyun Kim; Jang-Eun Cho; Jun Chang; Sung Jae Shin; Hyeyoung Lee; Young Ae Kang; Sang-Nae Cho; Sang-Jun Ha
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

3.  CXCR3 ligands as clinical markers for pulmonary tuberculosis.

Authors:  K Lee; W Chung; Y Jung; Y Kim; J Park; S Sheen; K Park
Journal:  Int J Tuberc Lung Dis       Date:  2015-02       Impact factor: 2.373

Review 4.  Tuberculosis biomarkers discovery: developments, needs, and challenges.

Authors:  Robert S Wallis; Peter Kim; Stewart Cole; Debra Hanna; Bruno B Andrade; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

5.  Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop.

Authors:  J Darren Campbell; Venu Gangur; F Estelle R Simons; Kent T HayGlass
Journal:  FASEB J       Date:  2003-12-04       Impact factor: 5.191

6.  Diagnostic utility of interferon-gamma-induced protein of 10 kDa (IP-10) in tuberculous pleurisy.

Authors:  Pokkali Supriya; Prabha Chandrasekaran; Sulochana D Das
Journal:  Diagn Microbiol Infect Dis       Date:  2008-07-11       Impact factor: 2.803

7.  Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity.

Authors:  S Narumi; T A Hamilton
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

8.  Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.

Authors:  Adane Mihret; Yonas Bekele; Kidest Bobosha; Martin Kidd; Abraham Aseffa; Rawleigh Howe; Gerhard Walzl
Journal:  J Infect       Date:  2012-11-20       Impact factor: 6.072

Review 9.  QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?

Authors:  Tom G Connell; Molebogeng X Rangaka; Nigel Curtis; Robert J Wilkinson
Journal:  Expert Rev Mol Diagn       Date:  2006-09       Impact factor: 5.225

10.  IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.

Authors:  Kristian Tonby; Morten Ruhwald; Dag Kvale; Anne Ma Dyrhol-Riise
Journal:  Sci Rep       Date:  2015-03-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.